RESUMEN
BACKGROUND: Alzheimer's disease (AD) prevention trials require a large outreach and screening funnel to identify cognitively unimpaired adults who meet the study's inclusion criteria, such as certain clinical or demographic criteria, genetic risk factors, and/or biomarker evidence of the disease. OBJECTIVES: Describe tactics and strategies to identify and enroll cognitively unimpaired adults with one (heterozygotes [HT]) or two (homozygotes [HM]) copies of the APOE ε4 allele, a genetic risk factor for dementia due to AD, into the Alzheimer's Prevention Initiative (API) Generation Program, the largest and only prevention trials for late onset AD using this enrichment technique. DESIGN AND SETTING: The Generation Program was comprised of two global, randomized, double-blind, placebo-controlled, parallel group adaptive design with variable treatment duration clinical trials. Generation Study 1 randomized participants into one of two cohorts: Cohort 1 which evaluated CAD106 vs. placebo or Cohort 2 which evaluated umibecestat vs placebo. Generation Study 2 randomized participants into two doses of umibecestat vs. placebo. The Generation Program was terminated early in 2019, while enrollment was still occurring. PARTICIPANTS: Both Generation Study 1 and Generation Study 2 enrolled cognitively unimpaired APOE ε4 HMs aged 60-75; Generation Study 2 also enrolled APOE ε4 HTs ages 60-75 with elevated brain amyloid. METHODS AND MEASUREMENTS: Describe results of the centralized and localized outreach, recruitment, screening strategies and tactics as well as characteristics of sites successful at enrolling genetically eligible participants, with a particular focus on APOE ε4 HMs given the 2-3% prevalence of this genotype. RESULTS: At the time the trial program was terminated, 35,333 individuals had consented to the optional prescreening ICF1a/ICFA and provided a sample of DNA for APOE genotyping, 1,138 APOE ε4 HMs consented to screening for Generation Study 1 (ICF1b), and 1,626 APOE ε4 carriers were randomized into either Generation Study 1 or Generation Study 2. Genetic testing registries, partnerships with genetic testing/counseling companies, and the optional prescreening ICF1a/ICFA were the most successful strategies for identifying genetically eligible participants for screening. CONCLUSIONS: It is feasible to recruit, screen and randomize cognitively unimpaired APOE ε4 carriers, particularly APOE ε4 HMs for a global AD prevention trial. The Generation Program was on track to complete enrollment by end of 2019. Factors that were key to this success included: working with sites to develop customizable outreach, recruitment, and screening programs specific to their site needs, providing forums for sites to exchange best practices, and developing partnerships between the sponsor team and trial sites.
Asunto(s)
Enfermedad de Alzheimer , Adulto , Humanos , Enfermedad de Alzheimer/diagnóstico , Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/prevención & control , Heterocigoto , Apolipoproteína E4/genética , Distribución Aleatoria , GenotipoRESUMEN
Trace amines have been implicated in a number of neuropsychiatric disorders including depression and schizophrenia. Although long known to modulate neurotransmission indirectly through the release of catecholamines, the identification of the Trace Amine 1 receptor (TA1) offers a mechanism by which trace amines can influence synaptic activity directly. TA1 binds and is activated by trace amines such as beta-phenylethylamine and tyramine. Our pharmacological characterization of mouse TA1 showed that, as in rat and primate, amphetamine is an agonist at this receptor but with surprisingly high potency. Without selective ligands for TA1 that do not also possess catecholamine-releasing properties, however, it has not been possible to study its physiological role in the central nervous system. To that end, a line of mice lacking the TA1 receptor was generated to characterize its contribution to the regulation of behavior. Compared with wild-type littermates, TA1 knockout (KO) mice displayed a deficit in prepulse inhibition. Knockout animals, in which the TA1-agonist influence of amphetamine was absent, showed enhanced sensitivity to the psychomotor-stimulating effect of this drug, which was temporally correlated with significantly larger increases in the release of both dopamine and norepinephrine in the dorsal striatum and associated with a 262% increase in the proportion of striatal high-affinity D2 receptors. TA1 therefore appears to play a modulatory role in catecholaminergic function and represents a potentially novel mechanism for the treatment of neuropsychiatric disorders. Furthermore, the TA1 KO mouse may provide a useful model for the development of treatments for some positive symptoms of schizophrenia.
Asunto(s)
Receptores Acoplados a Proteínas G/fisiología , Esquizofrenia/genética , Anfetamina/farmacología , Animales , Ansiedad/genética , Ansiedad/psicología , Conducta Animal/fisiología , Catecolaminas/metabolismo , Estimulantes del Sistema Nervioso Central/farmacología , Clonación Molecular , Modelos Animales de Enfermedad , Inhibidores de Captación de Dopamina/farmacología , Relación Dosis-Respuesta a Droga , Fiebre/genética , Fiebre/fisiopatología , Fiebre/psicología , Marcación de Gen , Masculino , Ratones , Ratones Noqueados , Microdiálisis , Actividad Motora/fisiología , Fenotipo , Receptores de Dopamina D2/efectos de los fármacos , Receptores de Dopamina D2/genética , Receptores de Dopamina D2/fisiología , Receptores Acoplados a Proteínas G/efectos de los fármacos , Receptores Acoplados a Proteínas G/genética , Reconocimiento en Psicología/fisiología , Reflejo de Sobresalto/genética , Reflejo de Sobresalto/fisiología , Psicología del Esquizofrénico , Estrés Psicológico/genética , Estrés Psicológico/fisiopatología , Estrés Psicológico/psicologíaRESUMEN
Tyramine, beta-phenylethylamine, tryptamine, and octopamine are biogenic amines present in trace levels in mammalian nervous systems. Although some "trace amines" have clearly defined roles as neurotransmitters in invertebrates, the extent to which they function as true neurotransmitters in vertebrates has remained speculative. Using a degenerate PCR approach, we have identified 15 G protein-coupled receptors (GPCR) from human and rodent tissues. Together with the orphan receptor PNR, these receptors form a subfamily of rhodopsin GPCRs distinct from, but related to the classical biogenic amine receptors. We have demonstrated that two of these receptors bind and/or are activated by trace amines. The cloning of mammalian GPCRs for trace amines supports a role for trace amines as neurotransmitters in vertebrates. Three of the four human receptors from this family are present in the amygdala, possibly linking trace amine receptors to affective disorders. The identification of this family of receptors should rekindle the investigation of the roles of trace amines in mammalian nervous systems and may potentially lead to the development of novel therapeutics for a variety of indications.
Asunto(s)
Aminas Biogénicas/química , Proteínas de Unión al GTP/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Aminas Biogénicas/metabolismo , Línea Celular , Mapeo Cromosómico , Cartilla de ADN , Humanos , Hibridación in Situ , Datos de Secuencia Molecular , Filogenia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Homología de Secuencia de AminoácidoRESUMEN
The central nervous system octapeptide, neuropeptide FF (NPFF), is believed to play a role in pain modulation and opiate tolerance. Two G protein-coupled receptors, NPFF1 and NPFF2, were isolated from human and rat central nervous system tissues. NPFF specifically bound to NPFF1 (K(d) = 1.13 nm) and NPFF2 (K(d) = 0.37 nm), and both receptors were activated by NPFF in a variety of heterologous expression systems. The localization of mRNA and binding sites of these receptors in the dorsal horn of the spinal cord, the lateral hypothalamus, the spinal trigeminal nuclei, and the thalamic nuclei supports a role for NPFF in pain modulation. Among the receptors with the highest amino acid sequence homology to NPFF1 and NPFF2 are members of the orexin, NPY, and cholecystokinin families, which have been implicated in feeding. These similarities together with the finding that BIBP3226, an anorexigenic Y1 receptor ligand, also binds to NPFF1 suggest a potential role for NPFF1 in feeding. The identification of NPFF1 and NPFF2 will help delineate their roles in these and other physiological functions.
Asunto(s)
Arginina/análogos & derivados , Oligopéptidos/metabolismo , Receptores de Superficie Celular/metabolismo , Receptores de Neuropéptido/química , Receptores de Neuropéptido/metabolismo , Secuencia de Aminoácidos , Animales , Arginina/metabolismo , Sitios de Unión , Encéfalo/metabolismo , Células COS , Calcio/metabolismo , Mapeo Cromosómico , Clonación Molecular , AMP Cíclico/metabolismo , ADN Complementario/metabolismo , Electrofisiología , Biblioteca de Genes , Humanos , Cinética , Ligandos , Datos de Secuencia Molecular , Oocitos , Fosfatidilinositoles/metabolismo , Unión Proteica , Estructura Terciaria de Proteína , ARN Mensajero/metabolismo , Ratas , Receptores de Superficie Celular/química , Receptores de Neuropéptido/biosíntesis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Homología de Secuencia de Aminoácido , Distribución Tisular , XenopusRESUMEN
Two structurally related, G-protein-coupled receptors were identified as receptors for the neuropeptide, neuromedin U. This peptide is found in highest levels in the gut and genitourinary system where it potently contracts smooth muscle but is also expressed in the spinal cord and discrete regions of the brain. Binding sites for neuromedin U have been characterized in rat uterus, however, little is known about the activity of this peptide in the regions of the central nervous system where it is expressed. The receptors characterized in this report are activated by neuromedin U at nanomolar potency in heterologous expression systems and bind radiolabeled neuromedin U with high affinity. Localization of the receptor RNA by quantitative reverse transcription-polymerase chain reaction in a variety of human tissues shows distinct expression patterns for the two receptors. NMU1 is expressed predominantly in peripheral tissues, whereas NMU2 is more highly expressed in the central nervous system. Identification of neuromedin U receptor subtypes will greatly aid in the determination of the physiological roles of this peptide.
Asunto(s)
Encéfalo/metabolismo , Proteínas de la Membrana , Receptores de Neurotransmisores/fisiología , Secuencia de Aminoácidos , Animales , Células COS , Calcio/metabolismo , Clonación Molecular , Secuencia Conservada , Femenino , Humanos , Fosfatos de Inositol/metabolismo , Datos de Secuencia Molecular , Neuropéptidos/farmacología , Oocitos/fisiología , Sistemas de Lectura Abierta , Especificidad de Órganos , Isoformas de Proteínas/química , Isoformas de Proteínas/genética , Isoformas de Proteínas/fisiología , Ensayo de Unión Radioligante , Ratas , Receptores de Neurotransmisores/química , Receptores de Neurotransmisores/genética , Proteínas Recombinantes/metabolismo , Sistemas de Mensajero Secundario/efectos de los fármacos , Sistemas de Mensajero Secundario/fisiología , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Porcinos , Transfección , Xenopus laevisRESUMEN
Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the mammalian central nervous system. GABA exerts its actions through two classes of receptors: GABA(A), multimeric ligand-gated Cl(-) ion channels (a class which has been proposed to include the homomeric variant previously called GABA(C), to be designated GABA(A0r)); and GABA(B), G-protein coupled receptors which regulate Ca(2+) and K(+) channels. Currently, within the GABA(B) receptor family two proteins have been identified through molecular cloning techniques and designated GABA(B1) and GABA(B2). Two N-terminal variants of GABA(B1) were isolated and designated GABA(B1a) and GABA(B1b). The distribution of neurons in the rat CNS expressing the mRNA for the GABA(B1) isoforms have been previously described by in situ hybridization histochemistry. The recent isolation and identification of the GABA(B2) protein by homology cloning has enabled the use of radiolabeled oligonucleotides to detect the distribution of the expression of GABA(B2) mRNA in the rat CNS. The expression of GABA(B2) mRNA was observed to be primarily related to neuronal profiles. The highest levels of GABA(B2) mRNA expression were detected in the piriform cortex, hippocampus, and medial habenula. GABA(B2) mRNA was abundant in all layers of the cerebral cortex, the thalamus and in cerebellar Purkinje cells. Moderate expression was observed in several hypothalamic and brainstem nuclei. In contrast to the distribution of GABA(B1) mRNA, only a weak hybridization signal for GABA(B2) was detected over cells of the basal ganglia, including the caudate-putamen, nucleus accumbens, olfactory tubercle and throughout most of the hypothalamus. Moderate-to-heavy GABA(B2) mRNA expression was also seen over dorsal root and trigeminal ganglion cells. In general, the pattern of GABA(B2) mRNA expression in the rat brain overlaps considerably with the distributions described for both GABA(B1) mRNAs, and is concordant with the distribution described for GABA(B) receptor binding sites. However, differences between GABA(B2) expression levels and GABA(B) binding sites were observed in the basal ganglia.
Asunto(s)
Sistema Nervioso Central/química , Receptores de GABA-B/genética , Receptores de GABA , Animales , Hibridación in Situ , Masculino , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley , Receptores de GABA-B/análisisRESUMEN
NPY is a 36-amino acid peptide which exerts its physiological effects through the activation of a family of G-protein coupled receptors. In vivo and in vitro characterization of the recently cloned rat Y5 receptor suggests that it is a primary mediator of NPY-induced feeding (Gerald et al., Nature 1996;382:168-171). We now report the molecular cloning and pharmacological characterization of the human, dog and mouse homologs of the Y5 receptor. With the exception of a 21 amino acid repeat in the amino terminus of the mouse Y5 receptor, the sequence of the four species homologs appear to be highly conserved, with 88% to 97% amino acid identities between any two species. Similarly, the pharmacological profiles of the four species homologs as determined in porcine 125I-PYY binding assays show a great deal of conservation, with the following rank order of affinity: human or porcine NPY, PYY, [Leu31,Pro34]NPY, NPY(2-36), human PP > human [D-Trp32]NPY > rat PP, C2-NPY. Northern blot analysis reveals that the Y5 receptor is widely distributed in the human brain, with the strongest signals detected in the cortex, putamen and caudate nucleus. The chromosomal localization of the human Y5 receptor, previously shown to be overlapping and in the opposite orientation to the Y1 receptor, is determined to be 4q31, the same locus as previously demonstrated for the human Y1 receptor (Herzog et al., J Biol Chem 1993;268:6703-6707), suggesting that these receptors may be coregulated. These Y5 species homologs along with corresponding animal models may be useful in the search for novel therapeutics in the treatment of obesity and related feeding disorders.
Asunto(s)
Receptores de Neuropéptido Y/genética , Receptores de Neuropéptido Y/metabolismo , Secuencia de Aminoácidos , Animales , Células COS , Cromosomas Humanos Par 4/genética , Clonación Molecular , Perros , Humanos , Hibridación Fluorescente in Situ , Cinética , Ratones , Datos de Secuencia Molecular , Neuropéptido Y/metabolismo , Polipéptido Pancreático/metabolismo , Péptido YY/metabolismo , Filogenia , Ratas , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Homología de Secuencia de Aminoácido , Especificidad de la Especie , TransfecciónRESUMEN
The rat GLYT-1 gene encodes two glycine transporter variants, GLYT-1a and GLYT-1b, that differ in NH2 termini and 5'-noncoding regions as well as in tissue distribution. The GLYT-1 gene contains 15 exons, with the first two specific for GLYT-1a and the third specific for GLYT-1b. By combining RNase protection and rapid amplification of cDNA ends analysis, we have determined transcription start sites for GLYT-1a and GLYT-1b. By using a functional luciferase reporter assay, we demonstrate that distinct promoters regulate the expression of these transporters in several cell lines. Serially truncated GLYT-1b promoter constructs reveal a basal promoter within 304 base pairs of the transcription start site, possible negative regulatory elements between -304 and -1310, and additional positive regulatory elements between -1310 and -5264. The GLYT-1 gene contains three sets of dinucleotide repeats, two AC repeats, and one TG repeat which may form stem-loop structures to either facilitate or interfere with transcription of one of the transporter isoforms. The potential use of dinucleotide repeats in this manner would represent a novel mechanism for gene splicing. The use of distinct promoters for GLYT-1a and GLYT-1b suggests that these transporters have unique regulatory requirements that may reflect the differential tissue-specific expression patterns in white matter (GLYT-1b) and gray matter (GLYT-1a).
Asunto(s)
Empalme Alternativo , Sistemas de Transporte de Aminoácidos Neutros , Proteínas Portadoras/genética , Glicina/metabolismo , Regiones Promotoras Genéticas , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Proteínas Portadoras/metabolismo , Clonación Molecular , ADN Complementario , Exones , Proteínas de Transporte de Glicina en la Membrana Plasmática , Intrones , Luciferasas/genética , Datos de Secuencia Molecular , Ratas , Transcripción Genética , Células Tumorales CultivadasRESUMEN
The neuropeptide galanin has been implicated in the regulation of processes such as nociception, cognition, feeding behavior, and hormone secretion. Multiple galanin receptors are predicted to mediate its effects, but only two functionally coupled receptors have been reported. We now report the cloning of a third galanin receptor distinct from GALR1 and GALR2. The receptor, termed GALR3, was isolated from a rat hypothalamus cDNA library by both expression and homology cloning approaches. The rat GALR3 receptor cDNA can encode a protein of 370 amino acids with 35% and 52% identity to GALR1 and GALR2, respectively. Localization of mRNA by solution hybridization/RNase protection demonstrates that the GALR3 transcript is widely distributed, but expressed at low abundance, with the highest levels in the hypothalamus and pituitary. We also isolated the gene encoding the human homologue of GALR3. The human GALR3 receptor is 90% identical to rat GALR3 and contains 368 amino acids. Binding of porcine 125I-galanin to stably expressed rat and human GALR3 receptors is saturable (rat KD = 0.98 nM and human KD = 2.23 nM) and displaceable by galanin peptides and analogues in the following rank order: rat galanin, porcine galanin approximately M32, M35 approximately porcine galanin-(-7 to +29), galantide, human galanin > M40, galanin-(1-16) > [D-Trp2]galanin-(1-29), galanin-(3-29). This profile resembles that of the rat GALR1 and GALR2 receptors with the notable exception that human galanin, galanin-(1-16), and M40 show lower affinity at GALR3. In Xenopus oocytes, activation of rat and human GALR3 receptors co-expressed with potassium channel subunits GIRK1 and GIRK4 resulted in inward K+ currents characteristic of Gi/Go-coupled receptors. These data confirm the functional efficacy of GALR3 receptors and further suggest that GALR3 signaling pathways resemble those of GALR1 in that both can activate potassium channels linked to the regulation of neurotransmitter release.
Asunto(s)
Canales de Potasio de Rectificación Interna , Receptores de Neuropéptido/genética , Secuencia de Aminoácidos , Animales , Unión Competitiva , Clonación Molecular , Conductividad Eléctrica , Canales de Potasio Rectificados Internamente Asociados a la Proteína G , Proteínas de Unión al GTP/metabolismo , Galanina/metabolismo , Humanos , Hipotálamo , Datos de Secuencia Molecular , Hipófisis , Canales de Potasio/metabolismo , Unión Proteica , Ratas , Receptores de Galanina , Receptores de Neuropéptido/clasificación , Homología de Secuencia de Aminoácido , Transducción de Señal , Especificidad de la Especie , Distribución TisularRESUMEN
We present the molecular cloning and characterization of the human galanin receptor, hGALR2. hGALR2 shares 85%, 39%, and 57% amino acid identities to rGALR2, hGALR1, and hGALR3, respectively. hGALR2, along with rGALR2, can be distinguished from the other cloned galanin receptors by a tolerance for both N-terminal extension and C-terminal deletion of galanin, as well as by a primary signaling mechanism involving phosphatidyl inositol hydrolysis and calcium mobilization. By RT-PCR, GALR2 mRNA was abundant in human hippocampus, hypothalamus, heart, kidney, liver, and small intestine. A weak GALR2 mRNA signal was detected in human retina, and no signal was detected in cerebral cortex, lung, spleen, stomach, or pituitary.
Asunto(s)
Receptores de Neuropéptido/química , Receptores de Neuropéptido/genética , Secuencia de Aminoácidos , Animales , Células CHO , Células Cultivadas , Clonación Molecular , Cricetinae , Humanos , Ratones , Datos de Secuencia Molecular , Especificidad de Órganos/genética , Unión Proteica , Ratas , Receptores de Galanina , Receptores de Neuropéptido/aislamiento & purificación , Receptores de Neuropéptido/metabolismo , PorcinosRESUMEN
The principal inhibitory neurotransmitter GABA (gamma-aminobutyric acid) exerts its effects through two ligand-gated channels, GABA(A) and GABA(C) receptors, and a third receptor, GABA(B) , which acts through G proteins to regulate potassium and calcium channels. Cells heterologously expressing the cloned DNA encoding the GABA(B)R1 protein exhibit high-affinity antagonist-binding sites, but they produce little of the functional activity expected from studies of endogenous GABA(B) receptors in the brain. Here we describe a new member of the GABA(B) polypeptide family, GABA(B)R2, that shows sequence homology to GABA(B)R1. Neither GABA(B)R1 nor GABA(B)R2, when expressed individually, activates GIRK-type potassium channels; however, the combination of GABA(B)R1 and GABA(B)R2 confers robust stimulation of channel activity. Both genes are co-expressed in individual neurons, and both proteins co-localize in transfected cells. Moreover, immunoprecipitation experiments indicate that the two polypeptides associate with each other, probably as heterodimers. Several G-protein-coupled receptors (GPCRs) exist as high-molecular-weight species, consistent with the formation of dimers by these receptors, but the relevance of these species for the functioning of GPCRs has not been established. We have now shown that co-expression of two GPCR structures, GABA(B)R1 and GABA(B)R2, belonging to the same subfamily is essential for signal transduction by GABA(B) receptors.
Asunto(s)
Receptores de GABA-B/metabolismo , Receptores de GABA , Secuencia de Aminoácidos , Animales , Western Blotting , Células CHO , Células COS , Línea Celular , Cricetinae , Agonistas de Receptores GABA-B , Antagonistas de Receptores de GABA-B , Hipotálamo/metabolismo , Masculino , Datos de Secuencia Molecular , Mutación , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores de GABA-B/genética , Transfección , XenopusAsunto(s)
Transportadoras de Casetes de Unión a ATP/fisiología , Transporte Biológico/fisiología , Neurotransmisores/metabolismo , Neurotransmisores/fisiología , Transportadoras de Casetes de Unión a ATP/química , Sistema de Transporte de Aminoácidos X-AG , Animales , Secuencia de Bases , Ácido Glutámico/metabolismo , Datos de Secuencia Molecular , Estructura Molecular , Neurotransmisores/químicaRESUMEN
We have previously demonstrated that the inhibition of neurotransmitter uptake at dopamine (DA) terminals stimulates the hypothalamo-pituitary-adrenal axis. In the present study we investigated the role of central DA neuronal systems in the regulation of this axis. Administration of the DA uptake inhibitor GBR12909 (3-30 micrograms) into the third ventricle dose-dependently elevated serum adrenocorticotropin hormone (ACTH) levels in rats. GBR12909 (10 micrograms) elevated serum ACTH levels following administration into the paraventricular nucleus of the hypothalamus but not into the lateral ventricle. The administration of 6-OHDA into the third ventricle significantly decreased DA content in the hypothalamus and striatum and significantly attenuated the ACTH response to GBR12909 (10 micrograms, third ventricle or 10 mg/kg, i.p.). Conversely, 6-OHDA lesions of the medial forebrain bundle, which depleted 99% of DA in the caudate but did not decrease DA content in the hypothalamus, and did not attenuate the ACTH response to i.p. GBR12909. Measurement of GBR12909-induced inhibition of [3H]DA uptake into synaptosomal preparations indicates the presence of GBR12909-sensitive DA transporters in the region of the hypothalamus surrounding the third ventricle. The present findings suggest that an endogenous DA neuronal system terminating in the hypothalamus mediates the effects of stimulants on hypothalamo-pituitary-adrenal function and might play a role in the ongoing regulation of hypothalamo-pituitary-adrenal activity.
Asunto(s)
Hormona Adrenocorticotrópica/metabolismo , Ventrículos Cerebrales/fisiología , Dopamina/metabolismo , Sistema Hipotálamo-Hipofisario/fisiología , Hipotálamo/metabolismo , Actividad Motora/efectos de los fármacos , Neuronas/metabolismo , Inhibidores de la Captación de Neurotransmisores/farmacología , Piperazinas/farmacología , Sistema Hipófiso-Suprarrenal/fisiología , Prosencéfalo/fisiología , Conducta Estereotipada/efectos de los fármacos , Hormona Adrenocorticotrópica/sangre , Análisis de Varianza , Animales , Ventrículos Cerebrales/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Hipotálamo/efectos de los fármacos , Inyecciones Intraperitoneales , Inyecciones Intraventriculares , Cinética , Masculino , Neuronas/efectos de los fármacos , Oxidopamina/administración & dosificación , Oxidopamina/toxicidad , Piperazinas/administración & dosificación , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Prosencéfalo/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Técnicas Estereotáxicas , Sinaptosomas/efectos de los fármacos , Sinaptosomas/metabolismo , Factores de TiempoRESUMEN
We have isolated a cDNA encoding a high affinity, Na+/Cl(-)-dependent glycine transporter, GLYT-2, which is distinct from another glycine transporter, GLYT-1. While the 3' sequences of these two cDNAs are identical, the 5' noncoding regions and the N-termini are completely different. GLYT-1 is found only in the white matter of the CNS, while GLYT-2 is found in the gray matter of the CNS as well as in macrophages and mast cells in peripheral tissues. Our findings suggest that tissue-specific alternative splicing or alternative promoter usage from a single gene results in two mRNA products encoding similar but distinct glycine transporters. The anatomic distribution of GLYT-2 mRNA supports the emerging status of glycine as a supraspinal neurotransmitter and suggests that glycine may function as a chemical messenger outside the CNS.
Asunto(s)
Sistemas de Transporte de Aminoácidos Neutros , Química Encefálica , Proteínas Portadoras/genética , Variación Genética , Médula Espinal/química , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Proteínas Portadoras/análisis , Cloruros/farmacología , ADN/análisis , Proteínas de Transporte de Glicina en la Membrana Plasmática , Histocitoquímica , Hibridación in Situ , Leucemia Basofílica Aguda , Mastocitos/química , Datos de Secuencia Molecular , ARN Mensajero/análisis , Ratas , Sodio/farmacología , Distribución Tisular , Células Tumorales CultivadasRESUMEN
A stimulatory role for endogenous dopamine (DA) in the regulation of hypothalamo-pituitary-adrenal activity has previously been demonstrated. In the present study, the roles of D1 and D2 subtypes of DA receptors in the regulation of activity of the hypothalamo-pituitary-adrenal axis were investigated. The intraperitoneal administration of either the D1 agonist, SKF 383393 (1-phenyl-2,3,4,5 tetrahydro-(iH)-benzazepine-7,8diol HCl, 5-20 mg/kg) or the D2 agonist quinpirole (0.05-1 mg/kg) dose-dependently elevated both adrenocorticotropic hormone (ACTH) and corticosterone (CS) in serum. Similarly, administration of either SKF 38393 or quinpirole (1-100 micrograms) into the third ventricle dose-dependently elevated ACTH in serum. The response of ACTH to intraperitoneal SKF 38393 was blocked by pretreatment with the D1 antagonist SCH 23390 (1-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5 tetrahydro-1H-3-benzazepine, 0.25 mg/kg, i.p.) but not by the D2 antagonist sulpiride (50 mg/kg, i.p.). The response of ACTH to intraperitoneal injection of quinpirole was blocked by pretreatment with sulpiride and attenuated slightly by pretreatment with SCH 23390. Further, the co-administration of sub-maximum doses of SKF 38393 and quinpirole caused additive increases in ACTH in serum. These results suggest that both D1 and D2 subtypes of DA receptors contribute to the dopaminergic regulation of function of the hypothalamo-pituitary-adrenal axis and support a role for DA neurons in the hypothalamus in this response. Further, these findings suggest that the D1 and D2 receptors, mediating the response of the hypothalamopituitary-adrenal axis are not tightly coupled.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
2,3,4,5-Tetrahidro-7,8-dihidroxi-1-fenil-1H-3-benzazepina/farmacología , Benzazepinas/farmacología , Ergolinas/farmacología , Sistema Hipotálamo-Hipofisario/fisiología , Sistema Hipófiso-Suprarrenal/fisiología , Receptores de Dopamina D1/fisiología , Receptores de Dopamina D2/fisiología , Sulpirida/farmacología , Hormona Adrenocorticotrópica/sangre , Análisis de Varianza , Animales , Corticosterona/sangre , Relación Dosis-Respuesta a Droga , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Masculino , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Quinpirol , Ratas , Ratas Wistar , Receptores de Dopamina D1/efectos de los fármacos , Receptores de Dopamina D2/efectos de los fármacosRESUMEN
Many behavioral responses to cocaine become progressively exaggerated with chronic treatment. Most studies have focused on cocaine-induced locomotor stimulation and changes in the dopamine projection systems which mediate these actions. However, it is not clear if a uniform 'sensitization' develops in all dopamine systems during chronic stimulant administration. To test this possibility the neuroendocrine actions of cocaine which are mediated, in part, by hypothalamic dopamine neurons were evaluated after chronic cocaine administration. Treatment of rats with cocaine (15 mg/kg, 2x/day) markedly enhanced the locomotor response to cocaine after 3 and 7 days of chronic administration. In contrast, neither the stimulation of adrenocorticotropic hormone (ACTH)/corticosterone (CS) secretion nor the slight inhibition of prolactin caused by acute cocaine administration changed, although a small elevation of basal corticosterone secretion was observed after 7 days. These findings suggest that the marked sensitization observed in other dopamine systems does not occur in the hypothalamic dopamine neurons thought to mediate the neuroendocrine responses to cocaine during chronic administration, despite recently described commonalities in uptake and autoreceptor functions in these dopamine cell populations. This contrast suggests a role for long loop feedback systems unique to telencephalic dopamine systems or region-specific neurochemical adaptations in cocaine sensitization.
Asunto(s)
Conducta Animal/efectos de los fármacos , Cocaína/farmacología , Sistemas Neurosecretores/efectos de los fármacos , Hormona Adrenocorticotrópica/sangre , Animales , Corticosterona/sangre , Dopamina/metabolismo , Masculino , Actividad Motora/efectos de los fármacos , Actividad Motora/fisiología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Prolactina/sangre , Radioinmunoensayo , Ratas , Ratas EndogámicasRESUMEN
The acute administration of cocaine (5-20 mg/kg) to rats produced a dose-dependent elevation in both serum corticosterone and plasma adrenocorticotrophic hormone (ACTH). These elevations were maximal at 30 min and returned to basal values by 60 min. The dopamine (DA) uptake blockers GBR12909 and nomifensine, the norepinephrine uptake blocker desipramine, as well as the serotonin (5-HT) uptake blocker fluoxetine, also stimulated hypothalamo-pituitary-adrenal (HPA) axis activity, whereas the local anesthetic procaine did not. Pretreatment with haloperidol (0.2 mg/kg) significantly attenuated the elevations in corticosterone and ACTH elicited by cocaine, as well as the elevation in ACTH produced by GBR12909. Higher doses of haloperidol (1 or 3 mg/kg) also attenuated the HPA response to cocaine and GBR12909. Pretreatment with the D1 antagonist SCH23390, the D2 antagonist sulpiride, the D1/D2 antagonist fluphenazine, or the 5-HT2 antagonist ketanserin significantly decreased the ACTH elevations after cocaine. In contrast, neither the 5-HT antagonist cyproheptadine, the alpha-1 antagonist prazosin nor the beta adrenergic antagonist propranolol attenuated the ACTH response to cocaine. The present results suggest an important stimulatory role for DA in regulation of HPA activity, and a role for both DA and 5-HT in the adrenocortical stimulation by cocaine. Both D1 and D2 receptors appear to be involved in the dopaminergic component of this response.
Asunto(s)
Monoaminas Biogénicas/fisiología , Cocaína/farmacología , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Hormona Adrenocorticotrópica/sangre , Animales , Cocaína/administración & dosificación , Corticosterona/sangre , Dopamina/metabolismo , Dopamina/fisiología , Antagonistas de Dopamina , Haloperidol/farmacología , Inyecciones Intraperitoneales , Ketanserina/farmacología , Masculino , Neurotransmisores/metabolismo , Inhibidores de la Captación de Neurotransmisores/farmacología , Piperazinas/farmacología , Prazosina/farmacología , Propranolol/farmacología , Ratas , Ratas Endogámicas , Receptores Dopaminérgicos/clasificación , Receptores Dopaminérgicos/fisiología , Estimulación Química , Factores de TiempoRESUMEN
Previous studies demonstrated the existence of a waterborne pheromone secreted by receptive females of the amphipod crustaceanMicrodeutopus gryllotalpa which attracts males. The data were obtained by using a bioassay apparatus based on a two-choice test paradigm. The present study reports the results of additional tests employing this apparatus which have shed some light on the chemical nature of the pheromone. The bioactive substance was isolated from receptive female waters with anion exchange resin columns, but not with C-18 reverse-phase columns. This suggests that the substance is polar. Another finding of the present study was that effluents from the green algaUlva lactuca inhibit males' responses to the pheromone.
RESUMEN
There are two common alleles at the Amylase-2 locus in populations of Gammarus palustris, the salt marsh amphipod. Intensive sampling of individuals from two localities at Jamaica Bay revealed a consistent pattern of heterozygote deficiency.-Five possible sources of heterozygote deficiency were examined in this study. Four of them-selection against heterozygotes, null alleles at the locus, assortative mating for amylase genotype and inbreeding-are inconsistent with the evidence and are rejected. The fifth possibility, Wahlund effects due to genetic differentiation of the population, is tentatively accepted. Although there is no direct evidence for differentiation within this population, separate populations along the Eastern seaboard are highly differentiated in a nonclinal pattern. Furthermore, the Wahlund hypothesis is consistent with observations on differences in degree of deficiency exhibited among collections at Jamaica Bay.-Animals from this population exhibit feeding preferences correlated with genotype. Given the choice of two green algae, Enteromorpha or Ulva, the frequency of the slow allele among individuals choosing Enteromorpha was higher than among those choosing Ulva. This suggests that the animals assort themselves in the field into subpopulations with different allelic frequencies. This assortment could contribute to the maintenance of the polymorphism and to the observed heterozygote deficiency. We hypothesize that genotype influences behavior in this system through the action of enzyme on substrate, which determines the nature of the oligosaccharide pool liberated early in amylolysis.
RESUMEN
A choice-test apparatus designed to mimic field conditions was employed to test for the presence of waterborne attractants in the amphipod crustaceanGammarus palustris. It was found that both males and females were attracted to secretions from all conspecifics, but not to the secretions of a sympatric congener. When given the choice of secretions from different types of conspecifics, males behaved differently than females. Males were attracted more often to receptive females' and females were attracted more often to males' secretions. In the field, then, it is likely that all conspecifics travel toward each other, then sort themselves into competent heterosexual couples. The results suggest that this apparatus can be employed in future studies to determine the chemical nature of these pheromones.